Analysis Group to Present Research at ISPE 2026

Event:42nd International Society for Pharmacoepidemiology (ISPE) Annual Meeting
Dates: August 29–September 2, 2026
Host: International Society for Pharmacoepidemiology (ISPE)
Location: Milan, Italy

Analysis Group, a global leader in drug safety epidemiology and regulatory RWE, will co-moderate one podium presentation session and present five research posters at the 42nd International Society for Pharmacoepidemiology (ISPE) Annual Meeting.

On Monday, August 31, from 3:30 to 5:00 p.m. CEST, in the Gold Room, Vice President Marianne Cunnington will co-moderate podium session 2C, “How Do Exposed Pregnancies End?”

On Tuesday, September 1, from 11:30 a.m. to 1:00 p.m. CEST, during poster session B in the Exhibition South Hall, researchers from Analysis Group – including Managing Principals Maral DerSarkissian, Mei Sheng Duh, and Mihran Yenikomshian, and Vice Presidents Marianne Cunnington, Lynn Huynh, and Enrico Zanardo – will present the following posters:

  • B-011: Clinical Characteristics and Treatment Patterns in Cisplatin-Eligible versus Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Patients with Intent for Resection: A Multi-Country Retrospective Chart Review in Europe
  • B-054: Comparison of Patient Reported Outcomes in Interstitial Lung Disease with and without Pulmonary Hypertension: Interim Results from the PHINDER Study
  • B-063: Real World Continuity of Care for Medicare Patients with Plaque Psoriasis Treated with Tildrakizumab and Other Treatment Classes
  • B-249: More than Just Fit-for-Use Data: a Structured Framework to Support Real World Study Decision Making

On Wednesday, September 2, from 12:15 to 1:15 p.m. CEST, in the Exhibit Hall, Managing Principal Maral DerSarkissian will present a rare disease spotlight poster:

  • SLC-033: Clinical Characteristics Associated with Pulmonary Hypertension among Patients with Interstitial Lung Disease: Interim Results from the PHINDER Study

Further details on the podium presentation session and posters are available in our 2026 ISPE Presentation Guide. Analysis Group is a proud gold sponsor of this meeting.

View additional information